CSBTF Stock Price, Chart, Stats & News

Kuros Biosciences AG
Save
Kuros Biosciences AG (CSBTF) does not currently pay a dividend.
968.24M
Market cap
106.74x
Current P/E
–
Forward P/E
CSBTF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Kuros Biosciences AG, a biopharmaceutical firm headquartered in Schlieren, Switzerland, specializes in both bringing to market and advancing therapeutic solutions for tissue repair and bone regeneration. Its global reach extends across the United States, the European Union, and other international markets, with operations strategically divided into Medical Devices, Pharmaceuticals, and a Legacy Portfolio. The company's innovative product lineup includes several key orthobiologics.
Similar securities
Based on sector and market capitalization
Report issue





